Grainne et al. found that GATA6 regulates epithelial-mesenchymal transition and tumor dissemination and is a marker of adjuvant chemotherapy response in pancreatic ductal adenocarcinoma (PDAC) [31, 32]. The gene discussed is GATA6; the disease is pancreatic ductal adenocarcinoma.